Company profile
Jushi Holdings Inc.
OTC: JUSHF · Healthcare · Drug Manufacturers - Specialty & Generic
#265 of 1,418 Healthcare companies by revenue45th-percentile growth
EA Score
54DFH 60DQ 48GM 43SS 61
v0.1 · 65/100 weight · provisional
↑ workforce scale, operating margin · ↓ disclosure history, balance-sheet leverage
Methodology →Revenue TTM
$265.5M
Rev growth YoY (TTM)
+3.7%
Net income (FY)
-$68.6M
Employees
1,288
as of 2026-08-18
Market cap
$84.3M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$262.9M$262.9M2025
Net income-$68.6M-$68.6M2025
Operating income$4.9M$4.9M2025
Total assets$422.3M$422.3M2025
Liabilities$537.7M$537.7M2025
Equity-$115.3M-$115.3M2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Retail Cannabis100%
By geography
Not disclosed.
The read
What is Jushi Holdings Inc.’s revenue?
Jushi Holdings Inc. booked $262.9M in FY2025 revenue, growing 2.1% year over year — about the middle of the pack among Healthcare companies we track, at a -26.1% net margin.
Peers · Healthcare
Ligand Pharmaceuticals Incorporated80B+CareRx Corporation71BIovance Biotherapeutics, Inc.59CArvinas, Inc.61CTerrAscend Corp.55COmada Health62CNeighbors
Palm Beach →Key facts
CEOJames Cacioppo
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersBoca Raton, FL
ExchangeOTC: JUSHF
Employees1,288
IPO date2019-06-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.